English | Español
Patient Daily | Dec 8, 2025

Study shows no evidence of harm from using hydroxyurea during pregnancy
Patient Daily | Dec 8, 2025

FDA launches agency-wide deployment of agentic artificial intelligence
Patient Daily | Dec 8, 2025

Baylor College of Medicine hosts event reflecting on Hurricane Katrina's legacy
Patient Daily | Dec 8, 2025

Study finds disparities in AML diagnosis age and survival among Black and white patients
Patient Daily | Dec 8, 2025

Smartphone motion tests may help screen for early Parkinson’s-related dopamine loss
Patient Daily | Dec 8, 2025

Aza-ven combination outperforms standard induction chemo in new AML clinical trial
Patient Daily | Dec 8, 2025

Early-life smell exposure linked with higher lifelong obesity risk
Patient Daily | Dec 8, 2025

Pirtobrutinib matches or exceeds efficacy versus ibrutinib in CLL/SLL head-to-head trial

Trending
+ Pharmaceuticals
Patient Daily | Feb 3, 2026

Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
+ Pharmaceuticals
Patient Daily | Feb 2, 2026

Clinical trial landscape shifts globally as China increases role in innovation
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

FDA lifts hold on Intellia's phase III ATTR gene editing trial
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Summit Therapeutics’ ivonescimab faces key FDA decision as potential Keytruda competitor